Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ACE inhibitors reduce the risk of myocardial fibrosis post-cardiac injury: a systematic review.

The British journal of cardiology·2026
Same author

Author Correction: Immunisation of koalas against Chlamydia pecorum results in significant protection against chlamydial disease and mortality.

NPJ vaccines·2026
Same author

Current status and future directions of <i>Chlamydia pecorum</i> research: a scoping review (2010-2025).

Frontiers in veterinary science·2026
Same author

Koalas first: lessons from a wildlife Chlamydia vaccine.

Trends in microbiology·2026
Same author

Chlamydia spp., Bordetella bronchiseptica, and Phascolarctid Gammaherpesvirus 1 and 2 Infections in Koalas (Phascolarctos cinereus) in South East Queensland, Australia: Detection in Healthy Individuals and Those with Signs of Respiratory or Other Disease.

Journal of wildlife diseases·2026
Same author

Evaluation of Chlamydia pecorum major outer membrane protein vaccine a management tool in wild koala (Phascolarctos cinereus) populations.

Scientific reports·2025

Related Experiment Video

Updated: Feb 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Editorial: Novel strategies for developing vaccines bring encouraging progress

Peter Timms1

  • 1Faculty of Science, Health, Education and Engineering, University of Sunshine Coast, Locked Bag 4, Maroochydore DC, Brisbane, Queensland 4558, Australia.

Pathogens and Disease
|September 1, 2017
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Related Experiment Videos

Last Updated: Feb 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K